Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib.
Banasavadi-Siddegowda YK, Namagiri S, Otani Y, Sur H, Rivas S, Bryant JP, Shellbourn A, Rock M, Chowdhury A, Lewis CT, Shimizu T, Walbridge S, Kumarasamy S, Shah AH, Lee TJ, Maric D, Yan Y, Yoo JY, Kumbar SG, Heiss JD, Kaur B. Banasavadi-Siddegowda YK, et al. Among authors: shimizu t. Neurooncol Adv. 2022 Jun 20;4(1):vdac095. doi: 10.1093/noajnl/vdac095. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35875691 Free PMC article.
Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.
Otani Y, Sur HP, Rachaiah G, Namagiri S, Chowdhury A, Lewis CT, Shimizu T, Gangaplara A, Wang X, Vézina A, Maric D, Jackson S, Yan Y, Zhengping Z, Ray-Chaudhury A, Kumar S, Ballester LY, Chittiboina P, Yoo JY, Heiss J, Kaur B, Banasavadi-Siddegowda YK. Otani Y, et al. Among authors: shimizu t. Neuro Oncol. 2021 Sep 1;23(9):1481-1493. doi: 10.1093/neuonc/noab014. Neuro Oncol. 2021. PMID: 33556161 Free PMC article.
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy.
Otani Y, Yoo JY, Lewis CT, Chao S, Swanner J, Shimizu T, Kang JM, Murphy SA, Rivera-Caraballo K, Hong B, Glorioso JC, Nakashima H, Lawler SE, Banasavadi-Siddegowda Y, Heiss JD, Yan Y, Pei G, Caligiuri MA, Zhao Z, Chiocca EA, Yu J, Kaur B. Otani Y, et al. Among authors: shimizu t. Clin Cancer Res. 2022 Apr 1;28(7):1460-1473. doi: 10.1158/1078-0432.CCR-21-2347. Clin Cancer Res. 2022. PMID: 35022322 Free PMC article.
Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation.
Nair M, Khosla M, Otani Y, Yeh M, Park F, Shimizu T, Kang JM, Bolyard C, Yu JG, Kumar Banasavadi-Siddegowda Y, Lopez G, Kaur B, Pollock RE, Lee TJ, Old M, Yoo JY. Nair M, et al. Among authors: shimizu t. Cancers (Basel). 2020 Apr 23;12(4):1040. doi: 10.3390/cancers12041040. Cancers (Basel). 2020. PMID: 32340193 Free PMC article.
δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion.
Shimizu T, Ishida J, Kurozumi K, Ichikawa T, Otani Y, Oka T, Tomita Y, Hattori Y, Uneda A, Matsumoto Y, Date I. Shimizu T, et al. Mol Cancer Ther. 2019 Apr;18(4):812-822. doi: 10.1158/1535-7163.MCT-18-0138. Epub 2019 Mar 14. Mol Cancer Ther. 2019. PMID: 30872378
10,214 results
You have reached the last available page of results. Please see the User Guide for more information.